Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid Lubiprostone in Chronic Idiopathic Constipation
NCT01993875Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Oct 2013
- Primary completion
- Jan 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Lubicosa in chronic idiopathic constipation (CIC), sponsored by Mallinckrodt Pharmaceuticals. Started Oct 2013; status: completed.
02
Drugs
Lubicosa
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01993875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993875.